Pharma Reviews: India likely to block $1.3 bn Gland Pharma-Fosun deal

India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group's proposed $1.3 billion takeover of Indian drugmaker ...
Read more: India likely to block $1.3 bn Gland Pharma-Fosun deal